Dokumendiregister | Ravimiamet |
Viit | MSO-2/3368-2 |
Registreeritud | 04.07.2025 |
Sünkroonitud | 07.07.2025 |
Liik | Väljaminev kiri |
Funktsioon | MSO Meditsiiniseadmed |
Sari | MSO-2 Eesti turule lastavate/kasutusele võetavate/levitatavate seadmete teavitused ning EC sertifikaadid |
Toimik | MSO-2/2025 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | SJJ Solutions B.V. |
Saabumis/saatmisviis | SJJ Solutions B.V. |
Vastutaja | Karl Kalev Türk (RA, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: RA MSO <[email protected]>
Sent: Thu, 26 Jun 2025 13:08:51 +0000
To: Wessel Hornman <[email protected]>
Subject: Vs: Registration Zero Residual concept
Dear Wessel Hornman,
Thank you for your enquiry.
From your letter, we understand that you intend to distribute your manufactured medical devices in Estonia. In the case of distributing a higher risk class medical device in Estonia, there is a distribution notification requirement which is based on Medical Device Act § 26 (4):
Every undertaking who distributes on the market of Estonia a system or procedure pack of medical devices according to Article 22 of Regulation (EU) 2017/745 of the European Parliament and of the Council or a class IIa, IIb or III medical device classified according to Regulation (EU) 2017/745 of the European Parliament and of the Council or Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices or Council Directive 93/42/EEC concerning medical devices or class B, C or D in vitro diagnostic medical devices classified according to Annex VIII of Regulation (EU) 2017/746 of the European Parliament and of the Council, shall notify the State Agency of Medicines thereof within 10 days after distribution of the relevant medical device for the first time.
Notification about distribution can be completed through our national Medical Devices and Appliances Database (EMDDB) https://msa.sm.ee/ and is free of charge.
For actors outside of Estonia we can make an account manually, so it is possible to log into the database with username and password. For creating an account we need a contact person’s full name and an e-mail.
Therefore, should the EMDDB account be registered under your name? If not, please direct the responsible person in your organisation to contact us with a request for the account in the database.
Documents with the notifications of medical devices are following: Declaration of conformity, EC certificate, instruction for use and copy of the labelling or packaging. For more detailed information about the distribution process in general, please refer to the short guide available under „Forms“ in the database.
We also recommend that you familiarise yourself with the national legislation, Medical Devices Act, as it regulates the language requirements for medical devices as well as the aforementioned distribution requirement.
Please do not hesitate to contact me for further information or any questions.
Best regards,
Karl Kalev Türk
Specialist
Department of Medical Devices
State Agency of Medicines
[email protected]
1 Nooruse Street
50411 Tartu
Estonia
Phone: +372 737 4140
Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri.
This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal.
Saatja: Wessel Hornman <[email protected]>
Saatmisaeg: kolmapäev, 25. juuni 2025 13:30
Adressaat: RA MSO <[email protected]>
Teema: Registration Zero Residual concept
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Sir/Madam,
My name is Wessel Hornman, and I am working at SJJ Solutions B.V., a medical device company based in The Hague, The Netherlands. We have developed the 'Zero Residual' concept for tailored for intravitreal injections. The concept includes the following:
We are seeing increasing interest from ophthalmologists in Estonia and would like to start selling our products.
We have CE and 510(k) registration.
What are the next steps for registration in Estonia?
Looking forward to your reply.
Best regards,
Wessel Hornman
Business Developer
Prinses Alexialaan 70B – 2nd Floor | 2496XA The Hague – The Netherlands
T: +31 (0)6 24621721 | www.SJJSolutions.com
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Küsimused | 04.07.2025 | 3 | MSO-2/3368-1 | Sissetulev kiri | ra | SJJ Solutions B.V. |
Küsimused | 04.07.2025 | 3 | MSO-2/3368-3 🔒 | Sissetulev kiri | ra | SJJ Solutions B.V. |
Küsimused | 04.07.2025 | 3 | MSO-2/3368-5 🔒 | Sissetulev kiri | ra | SJJ Solutions B.V. |
Küsimused | 04.07.2025 | 3 | MSO-2/3368-6 🔒 | Väljaminev kiri | ra | SJJ Solutions B.V. |
Küsimused | 04.07.2025 | 3 | MSO-2/3368-4 🔒 | Väljaminev kiri | ra | SJJ Solutions B.V. |